Had chemo 6 round of fu and 6 of gem a
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
You've completed a significant course of chemotherapy, and now waiting for surgery approval is an important next step. Let me help you understand where you are in your treatment journey.
Understanding Your Chemotherapy
What You Received:
- 5-FU (Fluorouracil): A traditional chemotherapy drug that damages cancer cell DNA
- Gemcitabine (Gem): Another chemotherapy agent commonly used in pancreatic cancer
- 6 rounds of each: This is a standard neoadjuvant (pre-surgery) regimen
According to NCCN Guidelines for Pancreatic Cancer, this combination chemotherapy is used to:
- Shrink the tumor to make surgery possible
- Assess how your cancer responds to treatment
- Improve long-term survival outcomes
What Happens Now: The Surgery Approval Process
After completing chemotherapy, your surgical team is likely:
-
Re-evaluating your tumor with imaging (CT or MRI) to see:
- How much the tumor shrank
- Whether it's now resectable (surgically removable)
- If blood vessels are still involved
-
Assessing your overall health to ensure you can safely tolerate surgery
-
Determining the surgical approach — likely a Whipple procedure (pancreaticoduodenectomy) or distal pancreatectomy, depending on tumor location
Important Questions to Ask While Waiting for Approval
Since you're in this waiting period, here are specific questions for your surgical team:
-
"What do my recent imaging scans show? How much did the tumor respond to chemotherapy?"
- This tells you how well your cancer responded to treatment
-
"Am I now considered resectable (operable)? What factors went into this decision?"
- Understanding the surgical team's reasoning is crucial
-
"What type of surgery are you planning, and why?"
- Different pancreatic surgeries have different recovery profiles
-
"What happens after surgery? Will I need more chemotherapy?"
- According to ASCO Guidelines, adjuvant (post-surgery) chemotherapy is often recommended
-
"What is your center's experience with pancreatic surgery? What are your complication and mortality rates?"
- High-volume centers (>20 pancreatic surgeries/year) have better outcomes
-
"What should I do to prepare physically for surgery?" (nutrition, exercise, smoking cessation, etc.)
What to Expect After Surgery
According to the American Cancer Society and NCCN Guidelines:
- Recovery timeline: 4-6 weeks before returning to normal activities
- Adjuvant chemotherapy: Often recommended after surgery to reduce recurrence risk
- Follow-up monitoring: Regular imaging and CA 19-9 blood tests
- Pancreatic insufficiency: Some patients need enzyme supplements after surgery
Do You Have Any Test Results to Share?
If you have access to:
- Recent imaging reports (CT/MRI scans)
- CA 19-9 levels (tumor marker blood test)
- Pathology reports from your original diagnosis
- Any other lab values or scan results
I can help you understand what these results mean and what questions to ask your team about them.
What would be most helpful for you right now? Are there specific concerns about the surgery, recovery, or next steps you'd like to discuss?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2